R1 RCM Inc. (NASDAQ:RCM) Given Average Recommendation of “Hold” by Brokerages

R1 RCM Inc. (NASDAQ:RCMGet Free Report) has been given a consensus rating of “Hold” by the eighteen brokerages that are presently covering the stock, Marketbeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $15.41.

RCM has been the subject of several research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $19.00 price objective on shares of R1 RCM in a research report on Friday, June 28th. TD Cowen reaffirmed a “hold” rating and issued a $14.30 price objective (down from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Morgan Stanley lowered shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a research report on Thursday, August 8th. Robert W. Baird reaffirmed an “outperform” rating and issued a $18.00 price objective on shares of R1 RCM in a research report on Tuesday, July 2nd. Finally, Stephens downgraded shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 1st.

View Our Latest Stock Report on R1 RCM

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bardin Hill Management Partners LP lifted its holdings in R1 RCM by 98.7% in the 2nd quarter. Bardin Hill Management Partners LP now owns 525,211 shares of the healthcare provider’s stock valued at $6,597,000 after purchasing an additional 260,891 shares in the last quarter. Scientech Research LLC purchased a new position in R1 RCM in the 2nd quarter valued at $285,000. Sea Cliff Partners Management LP lifted its holdings in R1 RCM by 14.3% in the 2nd quarter. Sea Cliff Partners Management LP now owns 2,437,450 shares of the healthcare provider’s stock valued at $30,614,000 after purchasing an additional 305,672 shares in the last quarter. Millennium Management LLC raised its holdings in shares of R1 RCM by 8.1% during the 2nd quarter. Millennium Management LLC now owns 457,907 shares of the healthcare provider’s stock worth $5,751,000 after acquiring an additional 34,475 shares during the period. Finally, Dark Forest Capital Management LP raised its holdings in shares of R1 RCM by 67.5% during the 2nd quarter. Dark Forest Capital Management LP now owns 57,749 shares of the healthcare provider’s stock worth $725,000 after acquiring an additional 23,270 shares during the period. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Stock Performance

RCM stock opened at $14.18 on Wednesday. The firm has a market cap of $5.97 billion, a price-to-earnings ratio of -177.25 and a beta of 0.84. The firm has a 50-day simple moving average of $13.94 and a two-hundred day simple moving average of $13.01. R1 RCM has a one year low of $8.87 and a one year high of $15.26. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84.

R1 RCM (NASDAQ:RCMGet Free Report) last released its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.03. The business had revenue of $627.90 million during the quarter, compared to analyst estimates of $633.10 million. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The firm’s revenue was up 12.0% on a year-over-year basis. On average, equities analysts forecast that R1 RCM will post -0.24 EPS for the current fiscal year.

R1 RCM Company Profile

(Get Free Report

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.

See Also

Analyst Recommendations for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.